This is a preview of subscription content, access via your institution
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
AIDS Vaccine Advocacy Coalition. “Understanding the results of the AIDSVAX trial.” (2003).
Burton, D.R. & Weiss, R.A. Science 329, 770–773 (2010).
Walker, L.M. et al. Science 9, 285–289 (2009).
Wu, X. et al. Science 13, 856–861 (2010).
Scheid, J.F. et al. Science 16, 1633–1637 (2011).
Diskin, R. et al. Science 2, 1289–1293 (2011).
Mascola, J.R. & Haynes, B.F. Immunol. Rev. 254, 225–244 (2013).
Gauduin, M.-C. et al. Nat. Med. 3, 1389–1393 (1997).
Barouch, D.H. et al. Nature 503, 224–228 (2013).
Johnson, P.R. et al. Nat. Med. 15, 901–906 (2009).
Balazs, A.B. et al. Nat. 481, 81–84 (2012).
Gardner, M.R. et al. Nature 519, 87–91 (2015).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayden, E. Almighty antibodies? A new wave of antibody-based approaches aims to combat HIV. Nat Med 21, 657–659 (2015). https://doi.org/10.1038/nm0715-657
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0715-657
This article is cited by
-
Paediatric HIV infection: the potential for cure
Nature Reviews Immunology (2016)